Oxbryta (voxelotor) for the Treatment of Sickle Cell Disease

Oxbryta™ (voxelotor) is a haemoglobin S polymerisation inhibitor indicated for the treatment of sickle cell disease. Credit: Global Blood Therapeutics, Inc.



  • Oxbryta (voxelotor)
  • Oxbryta (voxelotor)
  • Oxbryta (voxelotor)